Answer
Ertapenem should not be used during pregnancy unless the potential benefit outweighs the possible risk to the foetus, because adequate, well-controlled studies in pregnant women have not been performed, although animal studies indicate no direct or indirect harmful effects on pregnancy, embryo-foetal development, birth or postnatal development.
Sources for this answer
- INVANZ 1g powder for concentrate for solution for infusionMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 28Document updated
Sources checked